Mark Faupel
Vermogen: 1 M $ op 30-06-2026
Vermogen: 1 M $ op 30-06-2026
Mark L.
Faupel is the founder of Guided Therapeutics, Inc., founded in 1992, serving as President, CEO, CFO, COO & Director.
Dr. Faupel is also the founder of MacKay Life Sciences, Inc...
Dr. Faupel is currently a Member at Shenghuo Medical LLC.
Formerly, Dr. Faupel was a Member at the European School of Oncology.
Dr. Faupel earned a doctorate from the University of Georgia.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-03-2025 | 4.824.361 ( 5% ) | 1 M $ | 30-06-2026 | |
| 18-03-2025 | 97 ( 18,65% ) | 23 $ | 30-06-2026 | |
| 18-03-2025 | 38 ( 8,68% ) | 9 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| GUIDED THERAPEUTICS, INC. | Algemeen Directeur | 06-03-2023 |
Shenghuo Medical LLC | Corporate Officer/Principal | - |
| Bedrijven | Functie | Einde |
|---|---|---|
MacKay Life Sciences, Inc.
MacKay Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops medical device and associated diagnostic systems to assist in detecting breast cancer | Oprichter | 01-01-1998 |
European School of Oncology | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
MacKay Life Sciences, Inc.
MacKay Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops medical device and associated diagnostic systems to assist in detecting breast cancer | Health Technology |
Guided Therapeutics, Inc.
Guided Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical diagnostic products | Health Technology |
European School of Oncology | |
University of Georgia
University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenghuo Medical LLC |
Kies jouw editie
Alle financiële informatie op nationaal niveau